Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
0.2100
+0.0029 (1.40%)
At close: Apr 24, 2025, 4:00 PM
0.2050
-0.0050 (-2.38%)
Pre-market: Apr 25, 2025, 4:37 AM EDT
Beyond Air Revenue
Beyond Air had revenue of $1.07M in the quarter ending December 31, 2024, with 174.17% growth. This brings the company's revenue in the last twelve months to $3.02M, up 338.75% year-over-year. In the fiscal year ending March 31, 2024, Beyond Air had annual revenue of $1.16M.
Revenue (ttm)
$3.02M
Revenue Growth
+338.75%
P/S Ratio
3.79
Revenue / Employee
$28,252
Employees
107
Market Cap
18.54M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
XAIR News
- 3 days ago - NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism - GlobeNewsWire
- 9 days ago - NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board - GlobeNewsWire
- 15 days ago - Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home - GlobeNewsWire
- 24 days ago - Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site - GlobeNewsWire
- 4 weeks ago - NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy - GlobeNewsWire
- 6 weeks ago - Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH - GlobeNewsWire
- 7 weeks ago - Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 2 months ago - Beyond Air, Inc. (XAIR) Q3 2025 Earnings Call Transcript - Seeking Alpha